Testing use of payers to facilitate evidence-based practice adoption: Protocol for a cluster-randomized trial

Todd Molfenter, Jee Seon Kim, Andrew Quanbeck, Terry Patel-Porter, Sandy Starr, Dennis McCarty

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: More effective methods are needed to implement evidence-based findings into practice. The Advancing Recovery Framework offers a multi-level approach to evidence-based practice implementation by aligning purchasing and regulatory policies at the payer level with organizational change strategies at the organizational level.Methods: The Advancing Recovery Buprenorphine Implementation Study is a cluster-randomized controlled trial designed to increase use of the evidence-based practice buprenorphine medication to treat opiate addiction. Ohio Alcohol, Drug Addiction, and Mental Health Services Boards (ADAMHS), who are payers, and their addiction treatment organizations were recruited for a trial to assess the effects of payer and treatment organization changes (using the Advancing Recovery Framework) versus treatment organization changes alone on the use of buprenorphine. A matched-pair randomization, based on county characteristics, was applied, resulting in seven county ADAMHS boards and twenty-five treatment organizations in each arm. Opioid dependent patients are nested within cluster (treatment organization), and treatment organization clusters are nested within ADAMHS county board. The primary outcome is the percentage of individuals with an opioid dependence diagnosis who use buprenorphine during the 24-month intervention period and the 12-month sustainability period. The trial is currently in the baseline data collection stage.Discussion: Although addiction treatment providers are under increasing pressure to implement evidence-based practices that have been proven to improve patient outcomes, adoption of these practices lags, compared to other areas of healthcare. Reasons frequently cited for the slow adoption of EBPs in addiction treatment include, regulatory issues, staff, or client resistance and lack of resources. Yet the way addiction treatment is funded, the payer's role-has not received a lot of attention in research on EBP adoption.This research is unique because it investigates the role of payers in evidence-based practice implementation using a randomized controlled design instead of case examples. The testing of the Advancing Recovery Framework is designed to broaden the understanding of the impact payers have on evidence-based practice (EBP) adoption.Trial registration: http://NCT01702142 (ClinicalTrials.gov registry, USA).

Original languageEnglish (US)
Article number50
JournalImplementation Science
Volume8
Issue number1
DOIs
StatePublished - May 10 2013

Fingerprint

Evidence-Based Practice
Buprenorphine
Organizations
Mental Health Services
Alcoholism
Substance-Related Disorders
Therapeutics
Opioid Analgesics
Opioid-Related Disorders
Organizational Innovation
Random Allocation
Research
Registries
Randomized Controlled Trials
Delivery of Health Care
Pressure

Keywords

  • Addiction treatment
  • Buprenorphine
  • Evidence-based practice implementation
  • Innovation

ASJC Scopus subject areas

  • Health Policy
  • Medicine(all)
  • Public Health, Environmental and Occupational Health
  • Health Informatics

Cite this

Testing use of payers to facilitate evidence-based practice adoption : Protocol for a cluster-randomized trial. / Molfenter, Todd; Kim, Jee Seon; Quanbeck, Andrew; Patel-Porter, Terry; Starr, Sandy; McCarty, Dennis.

In: Implementation Science, Vol. 8, No. 1, 50, 10.05.2013.

Research output: Contribution to journalArticle

Molfenter, Todd ; Kim, Jee Seon ; Quanbeck, Andrew ; Patel-Porter, Terry ; Starr, Sandy ; McCarty, Dennis. / Testing use of payers to facilitate evidence-based practice adoption : Protocol for a cluster-randomized trial. In: Implementation Science. 2013 ; Vol. 8, No. 1.
@article{5dcf91c031714c98aa06a8abb5da9b19,
title = "Testing use of payers to facilitate evidence-based practice adoption: Protocol for a cluster-randomized trial",
abstract = "Background: More effective methods are needed to implement evidence-based findings into practice. The Advancing Recovery Framework offers a multi-level approach to evidence-based practice implementation by aligning purchasing and regulatory policies at the payer level with organizational change strategies at the organizational level.Methods: The Advancing Recovery Buprenorphine Implementation Study is a cluster-randomized controlled trial designed to increase use of the evidence-based practice buprenorphine medication to treat opiate addiction. Ohio Alcohol, Drug Addiction, and Mental Health Services Boards (ADAMHS), who are payers, and their addiction treatment organizations were recruited for a trial to assess the effects of payer and treatment organization changes (using the Advancing Recovery Framework) versus treatment organization changes alone on the use of buprenorphine. A matched-pair randomization, based on county characteristics, was applied, resulting in seven county ADAMHS boards and twenty-five treatment organizations in each arm. Opioid dependent patients are nested within cluster (treatment organization), and treatment organization clusters are nested within ADAMHS county board. The primary outcome is the percentage of individuals with an opioid dependence diagnosis who use buprenorphine during the 24-month intervention period and the 12-month sustainability period. The trial is currently in the baseline data collection stage.Discussion: Although addiction treatment providers are under increasing pressure to implement evidence-based practices that have been proven to improve patient outcomes, adoption of these practices lags, compared to other areas of healthcare. Reasons frequently cited for the slow adoption of EBPs in addiction treatment include, regulatory issues, staff, or client resistance and lack of resources. Yet the way addiction treatment is funded, the payer's role-has not received a lot of attention in research on EBP adoption.This research is unique because it investigates the role of payers in evidence-based practice implementation using a randomized controlled design instead of case examples. The testing of the Advancing Recovery Framework is designed to broaden the understanding of the impact payers have on evidence-based practice (EBP) adoption.Trial registration: http://NCT01702142 (ClinicalTrials.gov registry, USA).",
keywords = "Addiction treatment, Buprenorphine, Evidence-based practice implementation, Innovation",
author = "Todd Molfenter and Kim, {Jee Seon} and Andrew Quanbeck and Terry Patel-Porter and Sandy Starr and Dennis McCarty",
year = "2013",
month = "5",
day = "10",
doi = "10.1186/1748-5908-8-50",
language = "English (US)",
volume = "8",
journal = "Implementation Science",
issn = "1748-5908",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Testing use of payers to facilitate evidence-based practice adoption

T2 - Protocol for a cluster-randomized trial

AU - Molfenter, Todd

AU - Kim, Jee Seon

AU - Quanbeck, Andrew

AU - Patel-Porter, Terry

AU - Starr, Sandy

AU - McCarty, Dennis

PY - 2013/5/10

Y1 - 2013/5/10

N2 - Background: More effective methods are needed to implement evidence-based findings into practice. The Advancing Recovery Framework offers a multi-level approach to evidence-based practice implementation by aligning purchasing and regulatory policies at the payer level with organizational change strategies at the organizational level.Methods: The Advancing Recovery Buprenorphine Implementation Study is a cluster-randomized controlled trial designed to increase use of the evidence-based practice buprenorphine medication to treat opiate addiction. Ohio Alcohol, Drug Addiction, and Mental Health Services Boards (ADAMHS), who are payers, and their addiction treatment organizations were recruited for a trial to assess the effects of payer and treatment organization changes (using the Advancing Recovery Framework) versus treatment organization changes alone on the use of buprenorphine. A matched-pair randomization, based on county characteristics, was applied, resulting in seven county ADAMHS boards and twenty-five treatment organizations in each arm. Opioid dependent patients are nested within cluster (treatment organization), and treatment organization clusters are nested within ADAMHS county board. The primary outcome is the percentage of individuals with an opioid dependence diagnosis who use buprenorphine during the 24-month intervention period and the 12-month sustainability period. The trial is currently in the baseline data collection stage.Discussion: Although addiction treatment providers are under increasing pressure to implement evidence-based practices that have been proven to improve patient outcomes, adoption of these practices lags, compared to other areas of healthcare. Reasons frequently cited for the slow adoption of EBPs in addiction treatment include, regulatory issues, staff, or client resistance and lack of resources. Yet the way addiction treatment is funded, the payer's role-has not received a lot of attention in research on EBP adoption.This research is unique because it investigates the role of payers in evidence-based practice implementation using a randomized controlled design instead of case examples. The testing of the Advancing Recovery Framework is designed to broaden the understanding of the impact payers have on evidence-based practice (EBP) adoption.Trial registration: http://NCT01702142 (ClinicalTrials.gov registry, USA).

AB - Background: More effective methods are needed to implement evidence-based findings into practice. The Advancing Recovery Framework offers a multi-level approach to evidence-based practice implementation by aligning purchasing and regulatory policies at the payer level with organizational change strategies at the organizational level.Methods: The Advancing Recovery Buprenorphine Implementation Study is a cluster-randomized controlled trial designed to increase use of the evidence-based practice buprenorphine medication to treat opiate addiction. Ohio Alcohol, Drug Addiction, and Mental Health Services Boards (ADAMHS), who are payers, and their addiction treatment organizations were recruited for a trial to assess the effects of payer and treatment organization changes (using the Advancing Recovery Framework) versus treatment organization changes alone on the use of buprenorphine. A matched-pair randomization, based on county characteristics, was applied, resulting in seven county ADAMHS boards and twenty-five treatment organizations in each arm. Opioid dependent patients are nested within cluster (treatment organization), and treatment organization clusters are nested within ADAMHS county board. The primary outcome is the percentage of individuals with an opioid dependence diagnosis who use buprenorphine during the 24-month intervention period and the 12-month sustainability period. The trial is currently in the baseline data collection stage.Discussion: Although addiction treatment providers are under increasing pressure to implement evidence-based practices that have been proven to improve patient outcomes, adoption of these practices lags, compared to other areas of healthcare. Reasons frequently cited for the slow adoption of EBPs in addiction treatment include, regulatory issues, staff, or client resistance and lack of resources. Yet the way addiction treatment is funded, the payer's role-has not received a lot of attention in research on EBP adoption.This research is unique because it investigates the role of payers in evidence-based practice implementation using a randomized controlled design instead of case examples. The testing of the Advancing Recovery Framework is designed to broaden the understanding of the impact payers have on evidence-based practice (EBP) adoption.Trial registration: http://NCT01702142 (ClinicalTrials.gov registry, USA).

KW - Addiction treatment

KW - Buprenorphine

KW - Evidence-based practice implementation

KW - Innovation

UR - http://www.scopus.com/inward/record.url?scp=84877256915&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84877256915&partnerID=8YFLogxK

U2 - 10.1186/1748-5908-8-50

DO - 10.1186/1748-5908-8-50

M3 - Article

C2 - 23663749

AN - SCOPUS:84877256915

VL - 8

JO - Implementation Science

JF - Implementation Science

SN - 1748-5908

IS - 1

M1 - 50

ER -